Detalhe da pesquisa
1.
Inequalities in the recovery of colorectal cancer services during the COVID-19 pandemic: a national population-based study.
Colorectal Dis
; 26(3): 486-496, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38302858
2.
Impact of patient choice and hospital competition on patient outcomes after rectal cancer surgery: A national population-based study.
Cancer
; 129(1): 130-141, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36259432
3.
What is the impact of hospital and surgeon volumes on outcomes in rectal cancer surgery?
Colorectal Dis
; 25(10): 1981-1993, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37705203
4.
Survival outcomes associated with completion of adjuvant oxaliplatin-based chemotherapy for stage III colon cancer: A national population-based study.
Int J Cancer
; 150(2): 335-346, 2022 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34520572
5.
Outcomes of colorectal cancer resection in patients with inflammatory bowel disease: a national population-based analysis in England and Wales.
Colorectal Dis
; 24(8): 965-974, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35362664
6.
Measuring variation in the quality of systemic anti-cancer therapy delivery across hospitals: A national population-based evaluation.
Eur J Cancer
; 178: 191-204, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36459767
7.
Development and validation of a coding framework to identify severe acute toxicity from systemic anti-cancer therapy using hospital administrative data.
Cancer Epidemiol
; 77: 102096, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35030349
8.
Validity of chemotherapy information derived from routinely collected healthcare data: A national cohort study of colon cancer patients.
Cancer Epidemiol
; 73: 101971, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34225249
9.
Phase I and pharmacokinetic study of intravenous irinotecan plus oral ciclosporin in patients with fuorouracil-refractory metastatic colon cancer.
J Clin Oncol
; 21(6): 1125-32, 2003 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12637480
10.
Balancing the efficacy and toxicity of chemotherapy in colorectal cancer.
Ther Adv Med Oncol
; 3(1): 43-52, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21789155
11.
Association of molecular markers with toxicity outcomes in a randomized trial of chemotherapy for advanced colorectal cancer: the FOCUS trial.
J Clin Oncol
; 27(33): 5519-28, 2009 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-19858398
12.
Predictive biomarkers of chemotherapy efficacy in colorectal cancer: results from the UK MRC FOCUS trial.
J Clin Oncol
; 26(16): 2690-8, 2008 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18509181
13.
Molecular markers of chemotherapeutic response and toxicity in colorectal cancer.
Expert Rev Anticancer Ther
; 7(4): 489-501, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17428170